{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:05:10Z","timestamp":1761609910184},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bprclinrheum.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.berh.2015.04.033","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T08:36:19Z","timestamp":1433752579000},"page":"77-89","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pain management in cryoglobulinaemic syndrome"],"prefix":"10.1016","volume":"29","author":[{"given":"Salvatore","family":"Scarpato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Quartuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Pietrogrande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Monti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2015.04.033_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-3-25","article-title":"Mixed cryoglobulinaemia","volume":"3","author":"Ferri","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.berh.2015.04.033_bib2","first-page":"123","article-title":"Classification of cryoglobulinemic syndrome","volume":"13","author":"Invernizzi","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2015.04.033_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00005-010-0106-x","article-title":"Dual peripheral actions of immune cells in neuropathic pain","volume":"59","author":"Machelska","year":"2011","journal-title":"Arch Immunol Ther Exp Warsz"},{"key":"10.1016\/j.berh.2015.04.033_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","article-title":"Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia","volume":"74","author":"Nemni","year":"2003","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.berh.2015.04.033_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1212\/WNL.53.4.861","article-title":"Neurologic complications associated with hepatitis C virus infection","volume":"53","author":"Tembl","year":"1999","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.berh.2015.04.033_bib6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ejpain.2011.04.013","article-title":"The impact of pain in patients with polyneuropathy","volume":"15","author":"Poliakov","year":"2011","journal-title":"Eur J Pain"},{"key":"10.1016\/j.berh.2015.04.033_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1749-6632.2001.tb05822.x","article-title":"Central neuroplasticity and pathological pain","volume":"933","author":"Melzack","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.berh.2015.04.033_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00482-010-0902-6","article-title":"Neuropathic pain and neuroplasticity in functional imaging studies","volume":"24","author":"Maih\u00f6fner","year":"2010","journal-title":"Schmerz"},{"key":"10.1016\/j.berh.2015.04.033_bib9","first-page":"391","article-title":"High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia","volume":"30","author":"Zaltron","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.berh.2015.04.033_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/ard.60.3.290","article-title":"Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia","volume":"60","author":"Lidove","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2015.04.033_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0035-3787(06)75056-1","article-title":"The presentation of viral hepatitis C infection without cryoglobulinaemia with a peripheral neuropathy. Five case reports","volume":"162","author":"Rafai","year":"2006","journal-title":"Rev Neurol Paris"},{"key":"10.1016\/j.berh.2015.04.033_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1468-1331.2003.00560.x","article-title":"Motor-axonal polyneuropathy associated with hepatitis C virus","volume":"10","author":"Costa","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.berh.2015.04.033_bib13","first-page":"444","article-title":"Recommendations for the management of mixed cryoglobulinaemia syndrome in hepatitis C virus-infected patients autoimmunity reviews","volume":"10","author":"The Italian Group for the Study of Cryoglobulinaemia (GISC)","year":"2010"},{"key":"10.1016\/j.berh.2015.04.033_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/092986708783330610","article-title":"Current and emerging therapeutic approaches in HCV-related mixed cryoglobulinaemia","volume":"15","author":"Sansonno","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.berh.2015.04.033_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1365-2036.1999.00581.x","article-title":"Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia","volume":"13","author":"Calleja","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.berh.2015.04.033_bib16","first-page":"1641","article-title":"Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinaemia and hepatitis B virus infection","volume":"23","author":"La Civita","year":"1996","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2015.04.033_bib17","first-page":"403","article-title":"Cryoglobulinaemia and hepatitis C: worsening of peripheral neuropathy after interferon alpha treatment","volume":"23","author":"Lidove","year":"1999","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.berh.2015.04.033_bib18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.10118","article-title":"Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review","volume":"25","author":"Boonyapisit","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.berh.2015.04.033_bib19","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinaemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.berh.2015.04.033_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-11-253948","article-title":"Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinaemia and severe liver disease","volume":"116","author":"Petrarca","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.berh.2015.04.033_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2007.06.008","article-title":"Efficacy of low dose rituximab for mixed cryoglobulinaemia","volume":"125","author":"Visentini","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.berh.2015.04.033_bib22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004836-200605000-00018","article-title":"Treatment of type II cryoglobulinaemia associated with hepatitis C with rituximab","volume":"40","author":"Pekow","year":"2006","journal-title":"Clin Gastroenterol"},{"key":"10.1016\/j.berh.2015.04.033_bib23","first-page":"1076","article-title":"Rituximab in cryoglobulinemic peripheral neuropathy","volume":"256","author":"Cavallo","year":"2009","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.berh.2015.04.033_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archderm.139.3.391","article-title":"Leg ulcers associated with cryoglobulinaemia: clinical study of 15 patients and response to treatment","volume":"139","author":"Auzerie","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.berh.2015.04.033_bib25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S1590-8658(00)80335-7","article-title":"Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis","volume":"32","author":"Mazzaro","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.berh.2015.04.033_bib26","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S1590-8658(07)80027-2","article-title":"Plasmapheresis in cryoglobulinemic neuropathy: a clinical study","volume":"39","author":"Scarpato","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.berh.2015.04.033_bib27","first-page":"187","article-title":"GISC protocol experience in the treatment of essential mixed cryoglobulinaemia","volume":"13","author":"Pioltelli","year":"1995","journal-title":"J\u00a0Clin Exp Rheumat"},{"key":"10.1016\/j.berh.2015.04.033_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002281-200205000-00006","article-title":"Treatment of chronic hepatitis C infection with cryoglobulinaemia","volume":"13","author":"Della Rossa","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2015.04.033_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jca.20166","article-title":"Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinaemia","volume":"23","author":"Ramunni","year":"2008","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.berh.2015.04.033_bib30","first-page":"S197","article-title":"Colchicine in the treatment of mixed cryoglobulinaemia","volume":"13","author":"Monti","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2015.04.033_bib31","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1161\/CIRCULATIONAHA.105.594481","article-title":"Letter regarding article by Imazio et\u00a0al. Colchicine in addition to conventional therapy for acute pericarditis","volume":"113","author":"Brucato","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2015.04.033_bib32","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1345\/aph.1E197","article-title":"Acute colchicine intoxication during clarithromycin administration","volume":"38","author":"Rollot","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.berh.2015.04.033_bib33","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1345\/aph.1H064","article-title":"Rhabdomyolysis in a patient treated with colchicine and atorvastatin","volume":"40","author":"Tufan","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.berh.2015.04.033_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.md.0000188565.48918.41","article-title":"Rhabdomyolysis: an evaluation of 475 hospitalized patients","volume":"84","author":"Melli","year":"2005","journal-title":"Med Baltim"},{"key":"10.1016\/j.berh.2015.04.033_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10067-007-0696-9","article-title":"Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin","volume":"27","author":"Francis","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2015.04.033_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9343(89)80607-2","article-title":"Low antigen-content diet in the treatment of patients with mixed cryoglobulinaemia","volume":"87","author":"Ferri","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.berh.2015.04.033_bib37","first-page":"65","article-title":"Therapeutical approach to the mild cryoglobulinemic syndrome: results from a retrospective cohort study","volume":"70","author":"Pietrogrande","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2015.04.033_bib38","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00000542-200112000-00029","article-title":"Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats","volume":"95","author":"Chen","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.berh.2015.04.033_bib39","first-page":"17","article-title":"Tramadol: seizures, serotonin syndrome, and coadministered antidepressants","volume":"6","author":"Sansone","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"issue":"1","key":"10.1016\/j.berh.2015.04.033_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.107.126052","article-title":"(-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel opioid receptor agonist\/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties","volume":"323","author":"Tzschentke","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.berh.2015.04.033_bib41","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.051528","article-title":"Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects","volume":"174","author":"Furlan","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.berh.2015.04.033_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4065\/mcp.2009.0534","article-title":"Pain management in the cirrhotic patient: the clinical challenge","volume":"85","author":"Chandok","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.berh.2015.04.033_bib43","first-page":"859","article-title":"SIAARTI recommendations for chronic non-cancer pain","volume":"72","author":"Ambrosio","year":"2006","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.berh.2015.04.033_bib44","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.berh.2015.04.033_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3344\/kjp.2010.23.2.99","article-title":"Pharmacologic management of chronic pain","volume":"23","author":"Hue Jung Park","year":"2010","journal-title":"Korean J Pain"},{"key":"10.1016\/j.berh.2015.04.033_bib46","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.berh.2015.04.033_bib47","first-page":"5","article-title":"The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice","volume":"21","author":"Murtagh","year":"2007","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.berh.2015.04.033_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00228-008-0570-y","article-title":"Role of active metabolites in the use of opioids","volume":"65","author":"Janet","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.berh.2015.04.033_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpainsymman.2004.02.021","article-title":"Opioids in renal failure and dialysis patients","volume":"28","author":"Dean","year":"2004","journal-title":"J\u00a0Pain Symptom Manag"},{"key":"10.1016\/j.berh.2015.04.033_bib50","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2174\/138945010791170879","article-title":"The use of major analgesics in patients with renal dysfunction","volume":"11","author":"Niscola","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.berh.2015.04.033_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0269216311406313","article-title":"A\u00a0systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project","volume":"25","author":"King","year":"2011","journal-title":"Palliat Med"},{"key":"10.1016\/j.berh.2015.04.033_bib52","first-page":"339","article-title":"Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients","volume":"335\u2013336","author":"Davison","year":"2008","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.berh.2015.04.033_bib53","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1526-4637.2008.00415.x","article-title":"Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain","volume":"9","author":"Turner","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.berh.2015.04.033_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pain.2008.11.010","article-title":"Vitamin D and chronic pain","volume":"141","author":"Straube","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.berh.2015.04.033_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","article-title":"Opioids and the management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used world health organization step III opioids","volume":"8","author":"Pergolizzi","year":"2008","journal-title":"Pain Pract"},{"key":"10.1016\/j.berh.2015.04.033_bib56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00520-006-0127-5","article-title":"The pharmacological importance of cytochrome CYP3A4 in the pallation of symptoms: review and recommendations for avoiding adverse drug interactions","volume":"15","author":"Abdo","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.berh.2015.04.033_bib57","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FTD.0b013e31815c16f5","article-title":"Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring","volume":"29","author":"Zhou","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.berh.2015.04.033_bib58","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2337\/diacare.20.11.1702","article-title":"Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation","volume":"20","author":"Kumar","year":"1997","journal-title":"Diabetes Care"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169421500042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169421500042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T21:21:14Z","timestamp":1537564874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169421500042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S152169421500042X"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2015.04.033","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pain management in cryoglobulinaemic syndrome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2015.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}